Legal & General Group Plc - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 139 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 3.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$100,000
+7.5%
2,646
-51.8%
0.00%
Q4 2020$93,000
+287.5%
5,492
+5.4%
0.00%
Q3 2020$24,000
-36.8%
5,211
-18.2%
0.00%
Q2 2020$38,000
+153.3%
6,367
-9.1%
0.00%
Q1 2020$15,000
-59.5%
7,001
-13.9%
0.00%
Q4 2019$37,000
-11.9%
8,131
-25.0%
0.00%
Q3 2019$42,000
-12.5%
10,844
+35.6%
0.00%
Q2 2019$48,000
-86.1%
7,998
-68.9%
0.00%
Q1 2019$345,000
+202.6%
25,748
+110.4%
0.00%
Q4 2018$114,000
-33.3%
12,2380.0%0.00%
Q3 2018$171,000
-7.6%
12,238
+4.8%
0.00%
Q2 2018$185,000
-15.5%
11,676
-8.6%
0.00%
Q1 2018$219,000
-26.5%
12,768
-5.8%
0.00%
Q4 2017$298,000
-28.4%
13,558
+31.9%
0.00%
Q3 2017$416,000
+44.4%
10,281
+8.7%
0.00%
Q2 2017$288,000
-13.0%
9,455
+3.1%
0.00%
Q1 2017$331,000
-0.3%
9,168
+39.2%
0.00%
Q4 2016$332,000
+71.1%
6,585
+75.5%
0.00%
Q3 2016$194,000
+14.8%
3,752
-8.0%
0.00%
Q2 2016$169,000
+5.6%
4,077
+5.4%
0.00%
Q1 2016$160,000
+16.8%
3,869
+15.8%
0.00%
Q4 2015$137,000
+168.6%
3,3420.0%0.00%
Q3 2015$51,000
-37.0%
3,3420.0%0.00%
Q2 2015$81,000
+2.5%
3,3420.0%0.00%
Q1 2015$79,000
-12.2%
3,3420.0%0.00%
Q4 2014$90,000
+125.0%
3,3420.0%0.00%
Q3 2014$40,0003,3420.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
BVF INC/IL 2,781,346$25,867,0003.38%
GREAT POINT PARTNERS LLC 2,398,409$22,305,0002.82%
Sofinnova Investments, Inc. 315,344$2,933,0000.36%
EcoR1 Capital, LLC 326,775$3,039,0000.30%
Rock Springs Capital Management LP 505,000$4,697,0000.22%
Hilltop Holdings Inc. 36,146$336,0000.08%
OXFORD ASSET MANAGEMENT LLP 285,237$2,653,0000.07%
PLATINUM INVESTMENT MANAGEMENT LTD 191,237$1,779,0000.06%
FOX RUN MANAGEMENT, L.L.C. 12,132$113,0000.06%
Virtus ETF Advisers LLC 31,427$292,0000.05%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders